Bill

Bill > A1669


NJ A1669

NJ A1669
Requires health insurers to limit copayments for insulin.


summary

Introduced
01/14/2020
In Committee
01/14/2020
Crossed Over
Passed
Dead
01/11/2022

Introduced Session

2020-2021 Regular Session

Bill Summary

This bill requires health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program, to provide coverage for insulin for the treatment of diabetes. The bill also requires health insurers (health, hospital and medical service corporations, commercial individual and group health insurers; health maintenance organizations, health benefits plans issued pursuant to the New Jersey Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program) to limit the copayment that may be required for an insulin prescription to $100 per 30 day supply of insulin.

AI Summary

This bill requires health insurers in New Jersey, including those that provide coverage through the Individual Health Coverage and Small Employer Health Benefits Programs, the State Health Benefits Program, and the School Employees' Health Benefits Program, to limit the copayment for insulin to $100 per 30-day supply. The bill also ensures that these health plans provide coverage for insulin for the treatment of diabetes if prescribed by a physician or nurse practitioner.

Committee Categories

Business and Industry

Sponsors (4)

Last Action

Combined with A954/653 (ACS) (on 02/13/2020)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...